Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cabotegravir Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    UK MHRA grants Mkt approval for ViiV's cabotegravir formulations prevent HIV-1
    UK MHRA grants Mkt approval for ViiV's cabotegravir formulations prevent HIV-1

    04 May 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168917&sid=2

    PHARMABIZ
    04 May 2024
    Share Share
    FDA approves first extended-release injectable, complete regimen for HIV
    FDA approves first extended-release injectable, complete regimen for HIV

    22 Jan 2021

    // EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/140642/fda-approves-first-extended-release-injectable-complete-regimen-for-hiv-cabenuva/

    EUROPEANPHARMACEUTICALREVIEW
    22 Jan 2021
    Share Share
    GSK's ViiV nabs first approval for HIV game-changer Cabenuva
    GSK's ViiV nabs first approval for HIV game-changer Cabenuva

    21 Mar 2020

    // K. Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/take-fda-gsk-s-viiv-scores-canadian-nod-for-once-monthly-hiv-regimen-cabenuva

    K. Blankenship FIERCE PHARMA
    21 Mar 2020
    Share Share
    Positive Recommendation by NICE for first anti-CGRP migraine therap
    Positive Recommendation by NICE for first anti-CGRP migraine therap

    12 Mar 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200312005055/en

    BUSINESSWIRE
    12 Mar 2020
    Share Share
    FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues
    FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues

    24 Dec 2019

    // Amber Tong ENDPTS

    https://endpts.com/fda-slams-gsks-monthly-hiv-injectable-with-crl-citing-manufacturing-issues/

    Amber Tong ENDPTS
    24 Dec 2019
    Share Share
    ViiV inks bNAb deal with National Institutes of Health
    ViiV inks bNAb deal with National Institutes of Health

    22 Nov 2019

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/viiv_inks_bnab_deal_with_national_institutes_of_health_1317944

    Anna Smith PHARMA TIMES
    22 Nov 2019
    Share Share